UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000003155
Receipt number R000003830
Scientific Title Long-term trial on the effect of mulberry leaf extract ingestion on postprandial glycemic control in pre-diabetic subjects
Date of disclosure of the study information 2010/03/01
Last modified on 2010/02/09 15:58:09

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Long-term trial on the effect of mulberry leaf extract ingestion on postprandial glycemic control in pre-diabetic subjects

Acronym

Long-term trial on the effect of mulberry leaf extract ingestion on postprandial glycemic control in pre-diabetic subjects

Scientific Title

Long-term trial on the effect of mulberry leaf extract ingestion on postprandial glycemic control in pre-diabetic subjects

Scientific Title:Acronym

Long-term trial on the effect of mulberry leaf extract ingestion on postprandial glycemic control in pre-diabetic subjects

Region

Japan


Condition

Condition

diabetes

Classification by specialty

Endocrinology and Metabolism

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Evaluation of the effect of long-term mulberry leaf extract ingestion on glycemic control

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

Fasting blood glucose, insulin, 1,5-anhydroglucitol, glycated hemoglobin, glycated albumin

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification

NO

Dynamic allocation

NO

Institution consideration


Blocking

NO

Concealment

Central registration


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Food

Interventions/Control_1

placebo tablet ingestion three times daily before each meals for 12 weeks; blood collection at week 0, 4, 8 and 12 of the ingestion period and at 4-week after withdrawal

Interventions/Control_2

Mulberry leaf extract tablet ingestion three times daily before each meals for 12 weeks; blood collection at week 0, 4, 8 and 12 of the ingestion period and at 4-week after withdrawal

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

65 years-old >=

Gender

Male and Female

Key inclusion criteria

Fasting plasma glucose in the range of 100-140 mg/dl

Key exclusion criteria

pregnancy, lactation, severe medical illnesses, and the concurrent use of any agent for the control of blood glucose

Target sample size

76


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Jun Kariya

Organization

Project M Co., Ltd.

Division name

President-director

Zip code


Address

T-Biz(306), 6-6-40 Aoba, Aramaki, Aoba-ku, Sendai

TEL


Email



Public contact

Name of contact person

1st name
Middle name
Last name

Organization

Project M Co., Ltd.

Division name

President-director

Zip code


Address

T-Biz(306), 6-6-40 Aoba, Aramaki, Aoba-ku, Sendai

TEL


Homepage URL


Email



Sponsor or person

Institute

Project M Co., Ltd.

Institute

Department

Personal name



Funding Source

Organization

Japan Science and Technology Agency

Organization

Division

Category of Funding Organization

Nationality of Funding Organization



Other related organizations

Co-sponsor

Tohoku University
National Agricultural Research Center for Tohoku Region
Nippon Medical School

Name of secondary funder(s)

Project M Co., Ltd.


IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

総医研クリニック(大阪府)


Other administrative information

Date of disclosure of the study information

2010 Year 03 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2008 Year 01 Month 19 Day

Date of IRB


Anticipated trial start date

2008 Year 02 Month 01 Day

Last follow-up date

2008 Year 09 Month 01 Day

Date of closure to data entry

2009 Year 04 Month 01 Day

Date trial data considered complete

2009 Year 04 Month 01 Day

Date analysis concluded

2009 Year 04 Month 01 Day


Other

Other related information



Management information

Registered date

2010 Year 02 Month 09 Day

Last modified on

2010 Year 02 Month 09 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000003830


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name